Skip to main content

Table 1 Clinicopathologic characteristics associated with survival in 2935 patients after curative gastrectomy for gastric cancer

From: Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy

 

No (%)

5-YSR

P* value

Age

  

0.000

 Mean ± SD

57.8 ± 11.95

  

 <60

1511 (51.5)

86.2

 

 ≥60

1424 (48.5)

78.8

 

Sex

  

0.303

 Male

1931 (65.8)

82.0

 

 Female

1004 (34.2)

83.9

 

ECOG PS

  

0.000

 0

1272 (43.3)

90.6

 

 1

1535 (52.3)

78.2

 

 2

56 (1.9)

53.5

 

 3

4 (1)

50.0

 

 4

1 (0)

0

 

 5

0 (0)

-

 

 Unknown

67 (2.3)

85.0

 

Resection extent

  

0.000

 TG

704 (24.0)

73.3

 

 STG

2212 (75.4)

85.7

 

 Others

19 (0.6)

68.1

 

Tumor size

  

0.000

 Mean ± SD

4.07 ± 2.80

  

 <5 cm

2004 (68.3)

91.0

 

 ≥5 cm

931 (31.7)

65.0

 

LI

  

0.000

 -

1784 (60.8)

94.5

 

 +

1130 (38.5)

64.3

 

 Unknown

16 (0.5)

  

VI

  

0.000

 -

2762 (94.1)

84.1

 

 +

141 (4.8)

53.5

 

 Unknown

26 (0.9)

  

NI

  

0.000

 -

2206 (75.2)

89.4

 

 +

697 (23.7)

62.2

 

 Unknown

25 (0.9)

  

Leuran classification

  

0.000

 Intestinal

1283 (43.7)

86.1

 

 Diffuse

993 (33.8)

79.9

 

 Mixed

601 (20.5)

69.4

 

 Unknown

58 (2.0)

  

Histology

  

0.000

 Differentiated

1358 (46.3)

85.5

 

 Undifferentiated

1577 (53.7)

80.1

 

Location

  

0.000

 Esophagus

34 (1.3)

72.3

 

 Upper 1/3

286 (9.7)

80.6

 

 Middle 1/3

947 (32.3)

83.2

 

 Lower 3

1632 (55.6)

82.9

 

 Duodenum

1 (0)

100

 

 Whole Stomach

11 (0.4)

53.3

 

 Unknown

24 (0.8)

100

 

Depth

  

0.000

 T1

1596 (54.4)

96.0

 

 T2

346 (11.8)

87.4

 

 T3

532 (18.1)

71.6

 

 T4a

442 (15.1)

47.7

 

 T4b

17 (0.5)

48.7

 

Total number of

   

Retrieved LN

   

Mean ± SD

41.62 ± 16.27

  

Total number of

   

Positive LN

   

Mean ± SD

2.56 ± 5.95

  

Nodal status

  

0.000

 N0

1887 (64.3)

94.3

 

 N1

366 (12.5)

79.8

 

 N2

308 (10.5)

71.2

 

 N3

373 (12.7)

39.3

 

TNM Stage

  

0.000

 I

1743 (59.4)

96.1

 

 II

553 (18.8)

80.9

 

 III

639 (21.8)

49.7

 
  1. Continuous variables are presented as the mean ± standard deviation
  2. No, number of patients; 5-YSR, 5-year survival rate; ECOG Eastern cooperative oncology group, PS Performance status, TG Total gastrectomy, STG Subtotal gastrectomy, LI Lymphatic invasion, VI Venous invasion, NI Neural invasion, LN Lymph node, TNM Tumor-node-metastasis
  3. *Log-rank test